Investigator
Michael Ghaly
RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC · funded by NCI
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $1.8M
- First award
- Aug 5, 2024
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Feb 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC23momentum
OncologyGrant-only
- RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC18momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R44
Cloud/Web-Based Platform for Quantitative SPECT Reconstruction of Therapeutic Radionuclides
$1.0MFeb 1, 2025NCIRADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLCNIH RePORTER · 11069459 (opens the source filing in a new tab)
- R44
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters
$750kAug 5, 2024NCIRADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLCNIH RePORTER · 11161557 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources